DanCann Pharma A/S’ CEO and CCO have subscribed for shares and warrants in the directed issue
COPENHAGEN, Denmark, 27 July 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announces that Jeppe Krog Rasmussen, Founder, Board Member and CEO at DanCann Pharma A/S has privately through his holding company (Xignotus Capital ApS) subscribed for 267,023 new shares, equivalent to a subscription amount of DKK 1,000,001.135, and 267,023 warrants in DanCann Pharma A/S and John Morell Frellsen has privately trough his holding company (Morellco Holding ApS) subscribed for 25,000 new shares, equivalent to a subscription amount of DKK 93,625, as well as 25,000